A combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetes
A Standard patent application filed on 22 December 1999 credited to Vanpoelje, Paul
;
Erion, Mark D
Details
Application number :
20583
Application type :
Standard
Application status :
SEALED
Under opposition :
No
Proceeding type :
Invention title :
A combination of FBPase inhibitors and insulin sensitizers for the treatment of diabetes
Inventor :
Vanpoelje, Paul
;
Erion, Mark D
Agent name :
SPRUSON & FERGUSON
Address for service :
GPO Box 3898 SYDNEY NSW 2001
Filing date :
22 December 1999
Associated companies :
Applicant name :
Metabasis Therapeutics, Inc.
Applicant address :
9390 Towne Centre Drive San Diego CA 92121 United States Of America